Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS Tumors
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
Miltenyi Biomedicine GmbH
OHSU Knight Cancer Institute
Eastern Cooperative Oncology Group
Children's Oncology Group
Children's Hospital of Philadelphia
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
NYU Langone Health
Dana-Farber Cancer Institute
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Children's Oncology Group
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Barbara Ann Karmanos Cancer Institute
National Cancer Institute (NCI)
National Cancer Institute (NCI)
St. Jude Children's Research Hospital